Scott D. Morenstein

Scott D. Morenstein has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Celator Pharmaceuticals Inc, Molecular Templates, Inc. and Madrigal Pharmaceuticals, Inc. We count 10 filings; the first trade dates from 10 February 2014 and the latest from 21 November 2019.

The open-market record is one-sided, with 3 purchases worth €5.9M and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 share grant. 2019 to date brings 1 purchase and no sales.

The median purchase comes to €2.6M.

Most recently, on 25 November 2019, the filings show an open-market purchase worth €3.4M in Molecular Templates, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.